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Atf6Mineral trioxide aggregate (MTA) has been recommended for various uses in endodontics. To understand the ef-
fects of MTA on alveolar bone, we examined whether MTA induces osteoblastic differentiation using MC3T3-E1
cells. MTA enhanced mineralization concomitant with alkaline phosphatase activity in a dose- and time-
dependent manner. MTA increased production of collagens (Type I and Type III) and matrix metalloproteinases
(MMP-9 and MMP-13), suggesting that MTA affects bone matrix remodeling. MTA also induced Bglap
(osteocalcin) but not Bmp2 (bone morphogenetic protein-2) mRNA expression. We observed induction of Atf6
(activating transcription factor 6, an endoplasmic reticulum (ER) stress response transcription factor) mRNA ex-
pression and activation of Atf6 by MTA treatment. Forced expression of p50Atf6 (active form of Atf6) markedly
enhanced BglapmRNA expression. Chromatin immunoprecipitation assay was performed to investigate the in-
crease in p50Atf6 binding to the Bglap promoter region by MTA treatment. Furthermore, knockdown of Atf6
gene expression by introduction of Tet-on Atf6 shRNA expression vector abrogatedMTA-inducedmineralization.
These results suggest that MTA induces in vitro osteoblastogenesis through the Atf6–osteocalcin axis as ER stress
signaling. Therefore, MTA in endodontic treatment may affect alveolar bone healing in the resorbed region
caused by pulpal infection.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mineral trioxide aggregate (MTA), which is a bioactive inorganic
compound consisting of calcium silicate, calcium aluminate, calcium
aluminoferrite, calcium sulfate, and bismuth oxide, has been clinically
used for not only retrograde ﬁlling and apexiﬁcation but also repair of
accidental root perforations (Parirokh and Torabinejad, 2010;
Bernabé et al., 2013). Several studies have postulated microleakage
of MTA from the root in endodontic treatment (Lawley et al., 2004;
Yazdizadeh et al., 2013) and the other reported induction and/or
acceleration of bone repair of MTA in vivo (Qin et al., 2010; Wu
et al., 2013). These ﬁndings conducted us to explore molecular
mechanism(s) of healing action of MTA for the resorbed alveolar
bone due to endodontic infection.
Osteoblasts differentiate into bone forming phenotype frommesen-
chymal stem cell precursors in response to several factors, such as bone
morphogenetic proteins (BMPs), transforming growth factor (TGF) β1,
and vascular endothelial growth factor (VEGF) (Maeda et al., 2003).on and Molecular Biology, Ohu
chi, Koriyama 963-8611, Japan.
), bebas963@yahoo.co.jp
a@den.ohu-u.ac.jp (Y. Baba),
min.ac.jp (Y. Kato).
. This is an open access article underBone extracellular matrices (ECMs) consisting of Type I collagen,
osteocalcin, bone sialoprotein, osteopontin, and decorin have critical
roles in differentiation and mineralization. Generally, osteoblastogene-
sis is divided into three stages depending on differentiation usingmark-
er protein expression: e.g., alkaline phosphatase (ALP, early phase),
bone sialoprotein (BSP, middle phase), osteopontin (middle phase),
and osteocalcin (late phase). Osteocalcin is a vitamin K-dependent
calcium-binding protein containing two or three γ-carboxyglutamic
acid residues in the molecule (Maeda et al., 2004; Price and Baukol,
1980), and is abundant in the bone and teeth as a noncollagenous pro-
tein except dental enamel. Bglap gene knockout mice develop hyperos-
tosis (Ducy et al., 1996).
The endoplasmic reticulum (ER) plays an important role in protein
maturation through the folding process. Accumulation of unfolded pro-
teins in the lumen of the ER disrupts ER homeostasis, which is known as
“ER stress”. The unfolded protein response (UPR) is an adaptive re-
sponse to ER stress, and iswidely conserved in eukaryotes for regulation
of proteinmaturation and protection from cell death. The ER stress reac-
tion element (ERSE) is cis-acting element with the consensus sequence
CCAATN9CCACG, which is known to be recognized by NF-Y/CBF (Roy
et al., 1996). Haze et al. (2001) also reported that the basic leucine
zipper (bZIP) protein Atf6 (p50Atf6) binds to the CCAAT consensus
sequence of ERSE. Atf6 is synthesized as a transmembrane precursor
protein (p90Atf6) of 90 kDa in the ER. It translocates to the Golgi bythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Ca2+-dependent Golgi-associated proteinases (S1P and S2P) to release
the transcriptionally active N-terminal fragment (p50Atf6) of 50 kDa in-
cluding the bZIP sequence (Ye et al., 2000; Chen et al., 2002). Atf6 is
thought to be a master regulator of the UPR to reduce ER stress along
with two other molecules, i.e., IRE1 (inositol requiring 1) and PERK
[PKR (protein kinase R)-like ER kinase] (Kaufman, 1999; Mori, 2000).
Involvement ER stress signaling in osteoblastenesis has been reported
(Jang et al., 2012; Liu et al., 2012; Wang et al., 2014a). In addition,
Hino et al. (2010) showed that ER stress marker expression was
down-regulated in osteoblasts of osteoporosis patients, suggesting ER
stress play an important role for osteoblastic differentiation. Expansion
of the ER capacity to prevent ER overload-induced apoptosis by increas-
ing production of ECM proteins, such as Type I collagen (Tohmonda
et al., 2011).
Although previous studies showed that MTA affected the differenti-
ation of odontoblasts and bone marrow stromal cells with elevated ex-
pression of some genes, such as Alp (alkaline phosphatase), Osx (Sp7,
osterix), Bglap (osteocalcin), and Col1a1 (Type I collagen) (Min et al.,
2008, 2009; Wang et al., 2014b; Zhao et al., 2012), molecular mecha-
nism of MTA-induced bone healing mechanisms remains unclear. The
present study was performed to determine whether MTA induces oste-
oblastic differentiation and tissue mineralization through the ER stress
signaling pathway.
2. Materials & methods
2.1. Reagents
ProROOT MTA was provided by Dentsply (Johnson City, TN). Isogen
total RNA extraction kit was purchased from Nippon Gene (Tokyo,
Japan). SYBR Premix Ex Taq II and enzyme-linked immunosorbent
assay (ELISA) kits for Mouse Gla-Osteocalcin and BMP-2 were from
Takara (Tokyo, Japan) and R&D Systems (Minneapolis, MN), respective-
ly. Alphamodiﬁed Eagle'sMEM (αMEM)was from ICNPharmaceuticals
(Aurora, OH). Alkaline phosphatase (ALP) determination kit (Lab Assay
ALP) were from Wako (Osaka, Japan). Blocking regent N102 was from
NOF (Tokyo, Japan). Immobilon-P PVDF membranes and chemilumi-
nescence reagent were from Merck Millipore (Billerica, MA). Avidin-
conjugated horseradish peroxidase (HRP) was from Bio-Rad (Hercules,
CA). Xfect Transfection Reagent was from Clontech (Mountain View,
CA). Geneticin was from Roche (Basel, Switzerland). Doxycycline was
from Sigma Aldrich (St-Louis, MO).
2.2. Vectors and transfection
The coding region of p50Atf6 was cloned by RT-PCR and inserted
into the p3 × FLAG-CMV-10 vector (Sigma-Aldrich, St-Louis, MO) to in-
tracellularly express N-terminal Flag-tagged p50Atf6 fusion protein. The
shRNA for Atf6 mRNA expression vector was constructed using the
pSingle-tTS-shRNA vector (Clontech,MountainView, CA)with anoligo-
nucleotide targeting Atf6. Target sequence to construct an inducible
shRNA expression vector for Atf6 using the pSingle-tTS-shRNA vector
was as follows: 5′-TCG AGG CTC AGA CAT GAA GGC AGA TTC AAG AGA
TCT GCC TTC ATG TCT GAG CTT TTT TAC GCG T-3′, where the target in
indicated in bold underlined italic font. The resultant plasmid was des-
ignated as pSingle-tTS-Atf6-shRNA. Vectors were transfectedwith Xfect
Transfection Reagent (Clontech).
2.3. Antibodies
Rabbit polyclonal antibodies against Atf6 and Type I collagen
were purchased from Abcam (Cambridge, UK). Rabbit polyclonal an-
tibodies against Type III collagen were from Santa Cruz (Dallas, TX).
Biotin-conjugated goat anti-rabbit IgG (H + L) was from JacksonImmunoResearch (West Grove, PA). Anti-glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) antibodywas from Gene Tex Inc. (Irvine, CA).
2.4. Cell and cell culture
MC3T3-E1 cells (a clonal pre-osteoblastic cell line derived from
newborn mouse calvaria) were grown in growth medium consisting
ofαMEMsupplementedwith 10% fetal bovine serum(FBS) as described
previously (Maeda et al., 2003). For differentiation of the cells, we used
differentiation medium consisting of growth medium supplemented
with 50 μg/mL ascorbate 2-phosphate, 10 mM β-glycerophosphate,
and 40 mM HEPES (pH 7.4).
2.5. Preparation of MTA solution
The culture medium soluble fraction of MTA was used for this assay
according to Hakki et al. (2009) with somemodiﬁcations. MTA powder
(1 g) was suspended in 50 mL of αMEM, swelled, and incubated for
2 weeks at 4 °C with gentle shaking to release biologically active sub-
stances from the powder. After centrifugation at 3000 × g for 15 min
at 4 °C, the supernatant used as stock solution (20 mg-powder/mL)
was diluted 20,000- and 8000-fold with αMEM to ﬁnal concentrations
of 1.0 μg/mL and 2.5 μg/mL, respectively, and used for the experiment
as MTA solution. The IC50 was 9.5 μg/mL. MTA saturated solution at
2.5 μg/mL contained 2.3 μM calcium and showed negligible levels of
mineral deposition without cells. It also did not affect the pH of the cul-
ture medium.
2.6. Alizarin Red S (AR-S) staining
Mineralizedmatrix in the plates was stained with AR-S. Brieﬂy, cells
were ﬁxed in 70% ethanol for 1 h at room temperature, washed
with Ca2+- and Mg2+-free Dulbecco's phosphate-buffered saline (PBS
(−)), and stained with 40 mM AR-S at pH 4.2 for 10 min at room tem-
perature. Next, they were washed ﬁve times with deionized water and
incubated in PBS (−) for 15 min to eliminate nonspeciﬁc staining. The
stained matrix was photographed using a digital camera. The red stain
was quantiﬁed using Molecular Imager (BioRad, Hercules, CA).
2.7. Measurement of ALP activity
The membrane fraction of the cells was extracted with 0.1 M Tris–
HCl (pH 7.2) containing 0.1% Triton X-100. ALP activity was determined
using a Lab Assay ALP kit (Wako, Osaka, Japan).
2.8. Measurement of osteocalcin and BMP-2 in conditioned medium (CM)
Each time point, culture medium was replaced with fresh medium
without FBS and cells were cultured for a further 24 h. CM from 24-
hour cultureswere collected and concentrated by acetone precipitation.
Osteocalcin and BMP-2 were measured by enzyme-linked immunosor-
bent assay (ELISA).
2.9. Inducible knockdown system
For knockdown of themouseAtf6 gene,we used theKnockout Single
Vector Inducible RNAi System. The sequence targeting Atf6 was cloned
into the pSingle-tTS-shRNA vector. Stably transfected cells were select-
ed by geneticin. Cloned cells showed signiﬁcant reduction of Atf6mRNA
product in the presence of 1 μg/mL doxycycline (Dox).
2.10. Real-time reverse-transcription polymerase chain reaction (RT-PCR)
Total RNAwas isolated with Isogen, and reverse-transcribed to syn-
thesize cDNAwith a High-Capacity cDNAReverse Transcription Kit (Life
Technologies, Rockville, MD). Resultant cDNA samples were ampliﬁed
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Dice Real Time System (TP-870; Takara, Tokyo, Japan). The level of
Actb (β-actin) mRNA was used as an internal control. The speciﬁc
primer sequences used are shown in Table 1.
2.11. Western blotting
Western blotting was performed essentially as described in our pre-
vious reports (Kato et al., 2005). Whole-cell lysates (10 μg/lane) were
separated by 7.5% or 10% SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred onto Immobilon-P PVDF membranes.
Membranes were blocked with TBS-T (20 mM Tris–HCl, pH 7.5,
150 mM NaCl, and 0.05% Tween 20) containing 20% blocking regent
N102, treated with ﬁrst antibody followed by incubation with biotin-
conjugated secondary antibody and avidin-conjugated horseradish
peroxidase. Signals were detected with enhanced chemiluminescence
reagents. In some cases, antibodies were stripped off from themem-
brane with stripping buffer consisting of 6 M guanidine hydrochlo-
ride, 20 mM Tris–HCl (pH 7.5), 0.2% Nonidet P-40, and 0.1 M β-
mercaptoethanol (Yeung and Stanley, 2009). Anti-GAPDH antibody
was used as a loading control.
2.12. Gelatin and casein substrate zymography
Zymography was performed as described in our previous reports
(Kato et al., 2005). Brieﬂy, gelatinlytic and caseinolytic activity in CM
were detected by 7.5% SDS-PAGE containing 0.1% gelatin or casein, re-
spectively. SDS in the gel was removed by Triton X-100 and enzyme re-
action was carried out in the presence of 10 mM CaCl2. The destained
bands in the gels, indicating proteolytic activities, were quantiﬁed
using Molecular Imager (BioRad, Hercules, CA).
2.13. Chromatin immunoprecipitation (ChIP) assay
ChIP was performed as described previously (Agata et al., 2001).
Brieﬂy,MC3T3-E1 cells were ﬁxedwith 1% formaldehyde and sonicated.
Target protein in the sample was precipitated by anti-Atf6 antibody or
non-immune IgG as a control. Real-time PCR was performed with the
co-precipitated oligonucleotide as the template. Input DNA was also
ampliﬁed by PCR for normalization. Primer sequences for ChIP assay
are shown in Table 1.Table 1
Primer sequences.
Targets Sequences Product
size
(bp)
Atf6 Forward GAT GCC TTG GGA GTC AGA CC 162
Reverse CCA ACT CCT CAG GAA CGT GCT
Bglap Forward GTG AGC TTA ACC CTG CTT GT 96
Reverse AGC ACA GGT CCT AAA TAG TGA TAC C
Bglap promoter Forward CAA TCA CCT ACC ACA GCA TCC TTT GGG T 77
Reverse GGG GAT GCT GCC AGG ACT AAT TGG G
Bmp2 Forward TGA CTG GAT CGT GGC ACC TC 112
Reverse CAG AGT CTG CAC TAT GGC ATG GTT A
Bmp4 Forward AGC CGA GCC AAC ACT GTG AG 68
Reverse TCA CTG GTC CCT GGG ATG TTC
Col1a1 Forward GAC ATG TTC AGC TTT GTG GAC CTC 119
Reverse GGG ACC CTT AGG CCA TTG TGT A
Col3a1 Forward AAC GGA GCT CCT GGC CCC AT 113
Reverse CCA TCA CTG CCC CGA GCA CC
Mmp9 Forward GCC CTG GAA CTC ACA CGA CA 85
Reverse TTG GAA ACT CAC ACG CCA GAA G
Mmp13 Forward TCC CTG GAA TTG GCA ACA AAG 120
Reverse GCA TGA CTC TCA CAA TGC GAT TAC
Actb Forward CAT CCG TAA AGA CCT CTA TGC CAA C 171
Reverse ATG GAG CCA CCG ATC CAC A3. Results
3.1. Promotion of mineralization in MC3T3-E1 cells by MTA
First, we examined whether MTA affects mineralized nodule forma-
tion by osteoblasticMC3T3-E1 cells. Alizarin Red-S staining showed that
MTA induced nodule formation in a dose-dependent manner (Fig. 1A
and B). ALP activity was also induced dose-dependently by MTA, and
statistical signiﬁcance was conﬁrmed from day 8 and later (Fig. 1C).
3.2. MTA increases collagen (Col1a1 and Col3a1) and MMP (Mmp9 and
Mmp13) mRNA expression
Type I collagen is a major extracellular matrix protein in bone. On
the other hand, Type III collagen, which is a ﬁbril-forming collagen, is
an important factor for formation of Type I collagen ﬁbers.MTA induced
accumulation of both Col1a1 and Col3a1 at mRNA expression level
(Fig. 2A–E). It should be noted that the maximum induction of Col3a1
mRNAexpression (day 4) occurred earlier than that of Col1a1mRNA ex-
pression (day 8) (Fig. 2D and E). This was in good agreement with the
roles of Type I and Type III collagen in ﬁber formation.Fig. 1. MTA induces mineralization of extracellular matrix in MC3T3-E1 cells. The cells
were cultured for 16 days in the absence or presence of MTA at indicated concentrations.
(A) AR-S staining was performed to examinemineralized nodule formation. (B) A quanti-
tative analysis of the intensity for AR-S staining was determined by Molecular Imager FX
(Bio-Rad). (C) The time course of stimulation of ALP activity by MTA in MC3T3-E1 cells.
ALP samples from whole-cell extracts were assayed using an ALP kit. Data represent the
means ± SEM (n= 4). Statistical signiﬁcance of differences between MTA treated group
and corresponding time-matched vehicle control is indicated by *P b 0.05 and ***P b 0.001.
Fig. 2.MTA induces collagen synthesis in MC3T3-E1 cells. (A) The cells were cultured for 8 days in the absence or presence of MTA at indicated concentrations. Whole-cell lysates were
subjected to western blotting (A). A quantitative analysis of intensity for each immunoreacted band for Type I collagenα1 (Co1a) (B) and Type III collagenα1 (Col3a) (C) was performed
byMolecular Imager FX (Bio-Rad). Total RNAwas extracted, reverse-transcribed and ampliﬁedby real-time PCRwith primer sets for Col1a1 and Col3a1. Data are expressed asmean±SEM
(n= 4). Statistical signiﬁcance of differences between MTA treated group and corresponding time-matched vehicle control is indicated by *P b 0.05 and ***P b 0.001.
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ating 3/4 N-terminal and 1/4 C-terminal fragments, as themajor ﬁbrous
collagen-degrading proteinase in mice. These fragments are rapidly de-
natured at physiological temperature and are degraded by MMP-2 and
MMP-9. MTA signiﬁcantly induced production of MMP-9 and MMP-13Fig. 3. Production of MMPs in MTA-treated MC3T3-E1 cells. The cells were cultured in the abse
medium. After 24 h, the conditioned medium was collected and concentrated. (A) MMP-9 wa
zymography and western blotting as the precursor. A quantitative analysis of the intensity o
extracted and determined mRNA expression ofMmp9 (C) andMmp13 (F) by real-time RT-PCR
MTA treated group and corresponding time-matched vehicle control is indicated by *P b 0.05,at bothmRNAand protein level, while their active formswere negligible
level (Fig. 3). MaximummRNA levels of both molecules were observed
on day 12 (Fig. 3C and F). This elevation was observed at a later phase
compared to the collagen expression peaks (see Fig. 2D and E), and it
showed good agreement with the osteocalcin expression peak (Fig. 4).nce or presence of MTA for 12 days. The medium was changed to serum-free conditioned
s detected by gelatin-zymography as the precursor. (D) MMP-13 was detected by casein-
f each band was performed by Molecular Imager FX (Bio-Rad) (B and E). Total RNA was
. Data represent the means ± SEM (n= 4). Statistical signiﬁcance of differences between
**P b 0.01 and ***P b 0.001. Zymo, zymography; WB, western blotting.
Fig. 4. Time course of Bglap mRNA expression (A) and osteocalcin secretion
(B) in MTA-treated MC3T3-E1. At the indicated time points, total RNA was ex-
tracted for real-time RT-PCR. To determine osteocalcin secretion, culture medi-
um was replaced with fresh medium and the cells were further cultured with
or without MTA at the indicated concentration for 24 h. Osteocalcin concentra-
tion was measured using a mouse osteocalcin ELISA kit. Data represent the
means ± SEM. Statistical signiﬁcance of differences between MTA treated
group and corresponding time-matched vehicle control is indicated by
***P b 0.001. NS, not signiﬁcant.
Fig. 5.MTA induced Atf6 expression but did not BMP-2 and4 inMC3T3-E1 cells. Total RNAwas e
Bmp2 (A), Bmp4 (B), and Atf6 (D). (C) To determine BMP-2 protein secretion, culturemediumw
with orwithoutMTA for 24h. TheCMwas analyzed for BMP-2 concentration using a BMP-2 ELIS
concentration. Whole-cell lysates were subjected to immunoblotting with anti-Atf6 and GAPD
Molecular Imager FX (Bio-Rad). Total Atf6 was calculated as sum of intensities of p90 and p50
tween MTA treated group and corresponding time-matched vehicle control is indicated by ***
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by MTA
As BMP signal through the expression of Runx2 enhances Bglap gene
expression (Guo et al., 2012; Liu et al., 2013) and the Bglap gene was
also driven by Atf6 (Jang et al., 2012), we examined Bmp-2, Bmp-4,
and Atf6 expression in the presence or absence of MTA. MTA treatment
affected neither BMP-2 nor BMP-4 expression (Fig. 5A–C). Similarly,
there was no signiﬁcant difference in BMP-2 protein level between
MTA treated and untreated control groups.
Interestingly, Atf6 gene expression was signiﬁcantly upregulated by
MTA treatment on day 8 as the maximum induction (Fig. 5D), while
mRNA levels of the other ER stress signaling transducer such as Atf4
and OASIS (old astrocyte speciﬁcally induced substance) were not
changed (data not shown). Western blotting analysis showed a signiﬁ-
cant increase in Atf6 production by MTA treatment (Fig. 5E). As the ac-
tivation ratio (p50Atf6 vs. total Atf6; 0.54 in control, 0.47 in 1 μg/mL
MTA, 0.45 in 2.5 μg/mLMTA) did not changemarkedly, it was suggested
that the MTA-induced increase in p50Atf6, the active form of Atf6, was
due to enhancement of production rather than its activation efﬁciency
(Fig. 5F).
3.4. Atf6 contributes to MTA-stimulated mineralization
To obtain direct evidence regarding the contribution of Atf6 in MTA-
stimulated bone formation, we investigated whether p50Atf6 was tran-
scriptionally active by MTA treatment. Because p50Atf6 drives the Bglap
gene promoter (Jang et al., 2012), we performed ChIP assay for the pro-
moter region of Bglap gene. Expectedly, MTA treatment led to more sig-
niﬁcant binding Atf6 to the promoter region of the Bglap gene (Fig. 6).xtracted, reverse-transcribed, and ampliﬁedby real-time PCRusing speciﬁc primer sets for
as replacedwith freshmedium at the indicated time points and the culturewas continued
AKit. (E) The cellswere cultured for 12days in the absence or presenceofMTAat indicated
H antibodies. (F) A quantitative analysis of the intensity of each band was performed by
bands. Data represent the means ± SEM (n= 3). Statistical signiﬁcance of differences be-
P b 0.001. NS, not signiﬁcant.
Fig. 6. MTA stimulates Atf6 binding to promoter region of Bglap gene. The cells were
stimulated by MTA for 4 days. ChIP assays were performed. Cell lysates were incubated
with non-immune IgG control or ATF6 antibodies. (A) PCR ampliﬁcation of Bglap gene
promoters was performed using immunoprecipitated and non-immunoprecipitated
(input) DNA by using PCR thermal cycler. (B) A quantitative study of immunoprecipitated
DNA was performed by using real-time PCR. Data represent the means ± SEM (n= 3).
Statistical signiﬁcance of differences between MTA treated group and corresponding
time-matched vehicle control is indicated by ***P b 0.001.
Fig. 7. Forced expression of active Atf6 (p50Atf6) induces Bglap gene expression. The cells
were transiently transfected with a p3 × FLAGp50CMV10 or mock (p3 × FLAGCMV10) in
MC3T3-E1 cells and cultured for 2 days in osteogenic medium. (A) Protein level of Atf6
was analyzed by western blotting. (B) A quantitative study of intensity was performed
by Molecular Imager FX (Bio-Rad). (C) Bglap (osteocalcin) mRNA expression was
determined by real-time RT-PCR. Data represent the means ± SEM (n= 3). ***, P b 0.001.
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tive Atf6) expression vector and investigated if forced expression of ac-
tive Atf6 induces Bglap gene expression. Transient expression of the
dominant active Atf6 protein, the level of which was 2.5-fold higher
than the mock control, signiﬁcantly upregulated Bglap mRNA expres-
sion (Fig. 7).
Finally, we investigated whether Atf6 contributes to MTA-stimulated
mineralization. We constructed a Dox-inducible shRNA expression vec-
tor for Atf6 (pSingle-tTS-Atf6-shRNA) according to the Tet-on single-
vector inducible RNA interference system. After transfection of pSingle-
tTS-Atf6-shRNA vector into cells, stably transfected cells, whichwere se-
lected by geneticin, were cloned and obtained for mineralization assay.
Our data clearly showed that reduction of Atf6 expression by addition
of Dox attenuated MTA-stimulated BglapmRNA expression (Fig. 8) and
also mineralization (Fig. 9) to a level equivalent to that of the control.
These data suggested that MTA contributed to bone formation at least
in part through Atf6.
4. Discussion
Osteoblast differentiation is regulated by a number of hormones and
factors, such as TGF-β (transforming growth factor-β), BMP-2, and bFGF
(basic ﬁbroblast growth factor) (Hurley et al., 1994). Among them, BMP-
2 is the most effective inducer of proliferation, differentiation, and
mineralization in osteoblasts (Higuchi et al., 2002; Hiraki et al., 1991).
Previous studies have shown that MTA promoted osteoblastic minerali-
zation concomitant with increased BMP-2 mRNA expression (Ghasemi
et al., 2014; Jeong et al., 2014). Here, we also investigated MTA-
induced osteoblastic mineralization without BMP-2 mRNA elevation
compared to controls. Several recent reports have revealed the contribu-
tion of ER stress signaling in osteoblastic differentiation. For example,
Atf4 is enriched in osteoblasts and acts as a downstream effector of
PERK (pancreatic ER kinase) through elf-2α activation in ER stress
signaling to induce Bglap mRNA expression (Saito et al., 2011). Inaddition, it has been reported that Atf6 upregulates BglapmRNA level
(Jang et al., 2012) and that OASIS (old astrocyte speciﬁcally induced sub-
stance), which is amember of the CREB/Atf family, is highly expressed in
osteoblasts and contributes to bone formation (Murakami et al., 2009).
In the present study, we examined the expression of ER stress signaling
transducers, such as Atf4, Atf6, and OASIS. Among them, only Atf6 ex-
pression was upregulated byMTA treatment. Moreover, p50 the activat-
ed form Atf6 was dose-dependently increased by addition of MTA.
Because Atf6 plays an important role of differentiation in both odonto-
blast (Kim et al., 2014) and osteoblast (Jang et al., 2012), we examined
whether Atf6 is the candidate “MTA activated transcription factor” to in-
duce osteoblastic differentiation. As expected, MTA induced BglapmRNA
expression in a BMP-2-independentmanner. Mineralized nodule forma-
tion was enhanced by MTA treatment, but its timing was not changed.
Therefore, itwas suggested thatMTA inducedosteoblastic differentiation
at a rather late phase.
ER stress signaling plays an important role for expansion of the ER
capacity to prevent ER overload-induced apoptosis by increasing pro-
duction of ECMproteins, such as Type I collagen, and it is also associated
with osteoblastic differentiation (Hino et al., 2010; Tohmonda et al.,
2011). Here, we showed enhancement of tissue mineralization by
Fig. 8.Knockdown of Atf6 gene expression abolishes BglapmRNA expression andmineral-
ization byMTA. Stable clones of Atf6 shRNAwere incubatedwith (+) orwithout (−) Dox
and/or MTA for 16 days: MTA, 2.5 μg/mL; Dox, 1.0 μg/mL. (A) Whole-cell lysates were
subjected to immunoblotting with anti-Atf6 and GAPDH antibodies on day 12 in culture.
(B) A quantitative study for the intensity was performed by Molecular Imager FX (Bio-
Rad). (C) Bglap mRNA expression was decreased by Atf6 shRNA. On day 12 in culture,
total RNA was extracted from the cells, reverse-transcribed, and subjected to qPCR
analysis. Data represent the means ± SEM (n= 3). ***, P b 0.001; NS, not signiﬁcant.
Fig. 9. Attenuation of Atf6 expression does not induce mineralized nodule formation in
MTA-treated cells. The cells were cultured with (+) or without (−) Dox and/or MTA for
16 days: MTA, 2.5 μg/mL; Dox, 1.0 μg/mL. (A) AR-S staining was performed to examine
mineralized nodule formation. (B) A quantitative study of the intensity of the AR-S stain-
ingwas determined byMolecular Imager FX (Bio-Rad) (B, E). Data represent themeans±
SEM (n= 3). ***, P b 0.001; NS, not signiﬁcant.
42 T. Maeda et al. / Bone Reports 2 (2015) 36–43MTA is probably due to not simple induction of collagen production but
also activation of collagen remodeling. To accumulate and form collagen
ﬁbers, Type III collagen has been shown to trigger Type I collagen
ﬁbrillogenesis (Liu et al., 1997). In addition, Type III collagen has growth
stimulatory activity for osteoblasts (Maehata et al., 2007). Our data indi-
cated thatMTA increasednot only both Types I and III collagen synthesis
but also MMP-9 and MMP-13 expression. Several studies have shown
that induction of osteoblastic differentiation concomitantly increased
MMPs. For example, osteoblastic differentiation induced by ascorbate
2-phosphate concomitantly enhanced both MMP-9 and MMP-13 pro-
duction (Mizutani et al., 2001). The proteolytic cascade by MMP-2/
MMP-13/MT1-MMP was shown to be involved in osteoblastic differen-
tiation through mechanical forces (Barthelemi et al., 2012). In addition,
osterix, a master regulator of osteoblastic differentiation, induced both
MMP-1 (Nakashima et al., 2002) and MMP-13 (Zhang et al., 2012).
Our data indicated that maximal induction of Types III and I collagen
gene expression by MTA appeared on days 4 and 8, respectively.Mmp-9 andMmp-13mRNA expression were seen on day 12, just before
mineralization. Taken together, it seemed reasonable that MTA induced
MMPs during osteoblastic differentiation through collagen remodeling.
Our preliminary experiment showed strong toxicity for osteoblasts
near to the MTA disk. Therefore, we used the medium-soluble fraction
of MTA, according to the protocol (Hakki et al., 2009). The medium-
soluble fraction, which may contain biologically active substances re-
leased from MTA, did not show any obvious toxicity for MC3T3-E1
cells, but stimulated MMP, collagen, and osteocalcin mRNA expression.
Although MTA contains calcium silicate, bismuth oxide, and calcium
aluminate (Camilleri, 2008), the ratio of substances released from
MTAmay differ according to the protocol. This may explain the discrep-
ancies regarding BMP-2 expression by MTA. Our data, at least in part,
suggested that substances released from MTA in the root were able to
diffuse and affect distal osteoblasts in alveolar bone for late-stage differ-
entiation and tissue mineralization in vivo through ER stress signaling.5. Conclusions
Hashiguchi et al. (2011) investigated that MTA inhibits bone resorp-
tion. Taken together, we concluded that MTA in endodontic treatment
may affect alveolar bone healing in the resorbed region caused by pulpal
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